cagrilintide novo nordisk Nordisk's next-gen obesity drug CagriSema trial results disappoint investors No change' for CagriSema as
No change' for CagriSema as Novo ditches single chamber device Cagrilintide vs Retatrutide Compared Dosage Peptide Novo Nordisk's next generation weight loss drug CagriSema matches Lilly's Zepbound in major trial, but doesn't surpass it CNN Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



